Galena Biopharma Provides Product Pipeline Update at the American Society of Clinical Oncology 2013 Annual Meeting

Published: Jun 03, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LAKE OSWEGO, Ore., June 3, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced two publications at the American Society of Clinical Oncologists (ASCO) 2013 Annual Meeting taking place May 31-June 4 in Chicago, Illinois. The Company also provided an update on the ongoing Folate Binding Protein (FBP-E39) Phase 1/2 clinical trial.

Help employers find you! Check out all the jobs and post your resume.

Back to news